Manchester leads implementation of lifesaving genetic bedsidestroke test

Press/Media: Research

Description

An innovative bedside genetic test being implemented in Manchestercould dramatically improve outcomes for thousands of people in the UKaffected by stroke each year.

Period31 Jul 2024

Media coverage

1

Media coverage

  • TitleManchester leads implementation of lifesaving genetic bedsidestroke test
    Media name/outletManchester University NHS Foundation Trust
    Media typeWeb
    Country/TerritoryUnited Kingdom
    Date31/07/24
    DescriptionAn innovative bedside genetic test being implemented in Manchester could dramatically improve outcomes for thousands of people in the UK affected by stroke each year.

    Developed by researchers from Manchester University NHS Foundation Trust (MFT) and The University of Manchester, in collaboration with Manchester based company genedrive, the test can tell healthcare professionals in approximately one hour if stroke patients will be more likely to benefit from clopidogrel, the current first-line treatment to prevent recurrence.
    URLhttps://research.cmft.nhs.uk/news-events/manchester-leads-implementation-of-lifesaving-genetic-bedside-stroke-test
    PersonsWilliam Newman, John Mcdermott